357 related articles for article (PubMed ID: 8806453)
1. Alpha-melanocyte stimulating hormone-induced pigmentation is blocked by depletion of protein kinase C.
Park HY; Russakovsky V; Ao Y; Fernandez E; Gilchrest BA
Exp Cell Res; 1996 Aug; 227(1):70-9. PubMed ID: 8806453
[TBL] [Abstract][Full Text] [Related]
2. Activation of cAMP-dependent protein kinase is required for optimal alpha-melanocyte-stimulating hormone-induced pigmentation.
Ao Y; Park HY; Olaizola-Horn S; Gilchrest BA
Exp Cell Res; 1998 Oct; 244(1):117-24. PubMed ID: 9770355
[TBL] [Abstract][Full Text] [Related]
3. Regulation of melanogenesis in B16 mouse melanoma cells by protein kinase C.
Mahalingam H; Vaughn J; Novotny J; Gruber JR; Niles RM
J Cell Physiol; 1996 Sep; 168(3):549-58. PubMed ID: 8816909
[TBL] [Abstract][Full Text] [Related]
4. Eumelanin biosynthesis is regulated by coordinate expression of tyrosinase and tyrosinase-related protein-1 genes.
Kuzumaki T; Matsuda A; Wakamatsu K; Ito S; Ishikawa K
Exp Cell Res; 1993 Jul; 207(1):33-40. PubMed ID: 7686498
[TBL] [Abstract][Full Text] [Related]
5. Effect of pyrroloquinoline quinone (PQQ) on melanogenic protein expression in murine B16 melanoma.
Sato K; Toriyama M
J Dermatol Sci; 2009 Feb; 53(2):140-5. PubMed ID: 19013771
[TBL] [Abstract][Full Text] [Related]
6. Quercetin inhibits α-MSH-stimulated melanogenesis in B16F10 melanoma cells.
Yang YM; Son YO; Lee SA; Jeon YM; Lee JC
Phytother Res; 2011 Aug; 25(8):1166-73. PubMed ID: 21290442
[TBL] [Abstract][Full Text] [Related]
7. Independent regulation of tyrosinase by the hypopigmenting cytokines TGF beta1 and TNF alpha and the melanogenic hormone alpha-MSH in B16 mouse melanocytes.
Martínez-Esparza M; Solano F; García-Borrón JC
Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):991-1000. PubMed ID: 10644003
[TBL] [Abstract][Full Text] [Related]
8. Partially purified Curcuma longa inhibits alpha-melanocyte-stimulating hormone-stimulated melanogenesis through extracellular signal-regulated kinase or Akt activation-mediated signalling in B16F10 cells.
Jang JY; Lee JH; Jeong SY; Chung KT; Choi YH; Choi BT
Exp Dermatol; 2009 Aug; 18(8):689-94. PubMed ID: 19469902
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of melanogenesis inhibition by 2,5-dimethyl-4-hydroxy-3(2H)-furanone.
Lee J; Jung E; Lee J; Huh S; Boo YC; Hyun CG; Kim YS; Park D
Br J Dermatol; 2007 Aug; 157(2):242-8. PubMed ID: 17650175
[TBL] [Abstract][Full Text] [Related]
10. Effect of Angelica gigas extract on melanogenesis in B16 melanoma cells.
Lv N; Koo JH; Yoon HY; Yu J; Kim KA; Choi IW; Kwon KB; Kwon KS; Kim HU; Park JW; Park BH
Int J Mol Med; 2007 Nov; 20(5):763-7. PubMed ID: 17912471
[TBL] [Abstract][Full Text] [Related]
11. A new role for epidermal cell-derived thymocyte activating factor/IL-1 as an antagonist for distinct epidermal cell function.
Swope VB; Abdel-Malek ZA; Sauder DN; Nordlund JJ
J Immunol; 1989 Mar; 142(6):1943-9. PubMed ID: 2466081
[TBL] [Abstract][Full Text] [Related]
12. Characterization of density-dependent regulation of the tyrosinase gene promoter: role of protein kinase C.
Mahalingam H; Watanabe A; Tachibana M; Niles RM
Exp Cell Res; 1997 Nov; 237(1):83-92. PubMed ID: 9417870
[TBL] [Abstract][Full Text] [Related]
13. Effects of latanoprost on tyrosinase activity and mitotic index of cultured melanoma lines.
Dutkiewicz R; Albert DM; Levin LA
Exp Eye Res; 2000 May; 70(5):563-9. PubMed ID: 10870514
[TBL] [Abstract][Full Text] [Related]
14. NDRG2 gene expression in B16F10 melanoma cells restrains melanogenesis via inhibition of Mitf expression.
Kim A; Yang Y; Lee MS; Yoo YD; Lee HG; Lim JS
Pigment Cell Melanoma Res; 2008 Dec; 21(6):653-64. PubMed ID: 19067970
[TBL] [Abstract][Full Text] [Related]
15. β-Cryptoxanthin suppresses UVB-induced melanogenesis in mouse: involvement of the inhibition of prostaglandin E2 and melanocyte-stimulating hormone pathways.
Shimoda H; Shan SJ; Tanaka J; Maoka T
J Pharm Pharmacol; 2012 Aug; 64(8):1165-76. PubMed ID: 22775220
[TBL] [Abstract][Full Text] [Related]
16. Wnt/β-catenin signaling is stimulated by α-melanocyte-stimulating hormone in melanoma and melanocyte cells: implication in cell differentiation.
Bellei B; Pitisci A; Catricalà C; Larue L; Picardo M
Pigment Cell Melanoma Res; 2011 Apr; 24(2):309-25. PubMed ID: 21040502
[TBL] [Abstract][Full Text] [Related]
17. Selective increase of the alpha subspecies of protein kinase C and inhibition of melanogenesis induced by retinoic acid in melanoma cells.
Oka M; Ogita K; Saito N; Mishima Y
J Invest Dermatol; 1993 Feb; 100(2 Suppl):204S-208S. PubMed ID: 8433008
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of cAMP-specific PDE-4 activity following ligation of the TCR complex on thymocytes is blocked by selective inhibitors of protein kinase C and tyrosyl kinases.
Michie AM; Rena G; Harnett MM; Houslay MD
Cell Biochem Biophys; 1998; 28(2-3):161-85. PubMed ID: 9515165
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor alpha-mediated inhibition of melanogenesis is dependent on nuclear factor kappa B activation.
Englaro W; Bahadoran P; Bertolotto C; Buscà R; Dérijard B; Livolsi A; Peyron JF; Ortonne JP; Ballotti R
Oncogene; 1999 Feb; 18(8):1553-9. PubMed ID: 10102625
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of tyrosinase mRNA levels in melanoma cells by tumor promoters and by insulin.
Fuller BB; Niekrasz I; Hoganson GE
Mol Cell Endocrinol; 1990 Aug; 72(2):81-7. PubMed ID: 1704321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
